High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Pharmacogenomics Journal Année : 2014

High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase

Dates et versions

hal-01588451 , version 1 (15-09-2017)

Identifiants

Citer

M Lee, P Borgiani, I Johansson, F Oteri, M Mkrtchian, et al.. High warfarin sensitivity in carriers of CYP2C9*35 is determined by the impaired interaction with P450 oxidoreductase. Pharmacogenomics Journal, 2014, 14 (4), pp.343 - 349. ⟨10.1038/tpj.2013.41⟩. ⟨hal-01588451⟩
23 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More